Pimavanserin
RxNorm 1791685
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 1791685 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: pimavanserin.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
INPrescribable
Ingredient (IN):
Pimavanserin
(Atom ID: 8217239)
PTPrescribable
Designated preferred name (PT):
Pimavanserin
(Atom ID: 8718819)
FNPrescribable
Full form of descriptor (FN):
Pimavanserin (substance)
(Atom ID: 8718820)
PTPrescribable
Designated preferred name (PT):
Pimavanserin-containing product
(Atom ID: 10809202)
FNPrescribable
Full form of descriptor (FN):
Product containing pimavanserin (medicinal product)
(Atom ID: 10308586)
Patient Education
Pimavanserin
Pimavanserin is used to treat hallucinations and delusions in people with psychosis from Parkinson's disease (PD; a disorder of the nervous system that causes difficulties with movement, muscle control, and balance). Pimavanserin is in a class of medications called atypical antipsychotics. It works by changing the activity of certain natural substances in the brain.
[Learn More]
* Please review the disclaimer below.